Arbutus announces final results of its $230 million modified Dutch auction tender offer
ABUS•Arbutus Biopharma announced final results of its $230 million modified Dutch auction tender offer.
1. Tender offer results
Arbutus Biopharma announced final results of its $230 million modified Dutch auction tender offer.
Related News
BrightSpring Health updates calendar for third-quarter 2026 results release and call
BTSG•
Candel Therapeutics phase 2a NSCLC study shows 24.5-month median overall survival with aglatimagene plus valacyclovir after ICI failure
CADL•
